UPDATE 1-FTC focuses on psoriasis franchise for Bristol-Celgene deal review
March 26, 2019 at 11:58 AM EDT
The U.S. Federal Trade Commission has sought additional information from Bristol-Myers Squibb Co and Celgene Corp and is focusing on the companies' psoriasis treatments as part of its review of their planned merger, Bristol-Myers said on Tuesday.
